Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
Dermatopathology Section, Department of Pathology and Dermatology, University of California, San Francisco, CA.
Am J Surg Pathol. 2021 Feb 1;45(2):277-285. doi: 10.1097/PAS.0000000000001607.
A subset of Spitz tumors is associated with a copy number increase of chromosome 11p and activating mutations of HRAS. These aberrations have been reported to occur in association with desmoplastic Spitz nevi. Little is known to what extent 11p gains can also be found in nondesmoplastic tumors. To learn more about the spectrum of microscopic and cytogenetic changes that can be seen in Spitz lesions in association with 11p gains, we reviewed the clinical and pathologic features of 40 cases. Patient ages ranged from 3 to 75 years. The most common anatomic site was the head and neck region, followed by the upper extremities. Prominent desmoplasia was present in 10 cases. Seven tumors lacked significant stromal fibrosis. Twenty tumors were mitotically active. Novel microscopic features encountered in a few cases include a tumor with a polypoid silhouette and papillomatous surface and rare atypical tumors with a deep bulbous growth pattern. Among 36 cases analyzed by single-nucleotide polymorphism array or comparative genomic hybridization, 28 tumors had gains of the entire or near-entire p-arm of chromosome 11 with no other coexisting unbalanced genomic aberration. Eight cases had additional changes; 6 of these with 1 additional aberration per case, and 2 cases had several chromosomal aberrations. We also examined a subset of tumors by fluorescence in situ hybridization for the HRAS gene locus (11p15.5). All tumors were fluorescence in situ hybridization-positive. In conclusion, we expand the spectrum of pathologic findings associated with Spitz tumors with 11p gains. This cytogenetic aberration is not restricted to desmoplastic Spitz nevi. It can also be seen in nondesmoplastic and papillomatous lesions and atypical melanocytic tumors with a deep bulbous growth. We also document that in some Spitz tumors additional cytogenetic aberrations may be found, the significance of which remains to be determined.
Spitz 肿瘤的一个亚组与 11p 染色体的拷贝数增加和 HRAS 的激活突变相关。这些异常已被报道与促结缔组织增生性 Spitz 痣相关。关于 11p 增益也能在非促结缔组织增生性肿瘤中发现的程度,知之甚少。为了更多地了解与 11p 增益相关的 Spitz 病变中可见的微观和细胞遗传学变化的范围,我们回顾了 40 例病例的临床和病理特征。患者年龄从 3 岁到 75 岁不等。最常见的解剖部位是头颈部,其次是上肢。10 例存在明显的促结缔组织增生。7 例肿瘤缺乏明显的间质纤维化。20 例肿瘤有丝分裂活跃。在少数病例中遇到的新的微观特征包括具有息肉样轮廓和乳头状表面的肿瘤和罕见的具有深球状生长模式的非典型肿瘤。在通过单核苷酸多态性微阵列或比较基因组杂交分析的 36 例病例中,28 例肿瘤具有整个或几乎整个 11 号染色体 p 臂的增益,没有其他共存的非平衡基因组异常。8 例有额外的变化;其中 6 例每例有 1 个额外的异常,2 例有多个染色体异常。我们还通过荧光原位杂交检查了 HRAS 基因座(11p15.5)的一组肿瘤。所有肿瘤均为荧光原位杂交阳性。总之,我们扩大了与 11p 增益相关的 Spitz 肿瘤的病理发现范围。这种细胞遗传学异常不仅限于促结缔组织增生性 Spitz 痣。它也可见于非促结缔组织增生性和乳头状病变以及具有深球状生长的非典型黑素细胞肿瘤。我们还记录到,在一些 Spitz 肿瘤中可能会发现其他细胞遗传学异常,其意义仍有待确定。